CB vs IBIO · P/E 14, rev $59.40B vs rev $100.0K
Chubb Ltd (CB) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the CB and IBIO stock pages for the full models.
Not investment advice.